Tumor infiltration and signaling pathway for immune modulating cytokine IL-2 had a strong negative correlation with KIT expression, which is in line with our conclusion that KIT expression in neuroblastomas is not driven by immune infiltration (Figure 1C). This evidence concerns the gene KIT and neuroblastoma.